Health Care • Medical/Dental Instruments
$76.68 ▼ -9.06
(-10.57%)
MKT CAP: $1.10B • VOL: 218.1K
52W L $76 52W H $108
ROARABLE / RQD
C- • 59/100
PIOTROSKI
8 / 9
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$64
MEDIAN
$86
MEAN
$87
HIGH
$104
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE IRMD TAPE
IRMD // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $92.78 | $88.18 | 2025-02-14 | $69.78 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $96.62 | $90.48 | 2025-02-06 | $72.08 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $87.42 | $84.35 | 2025-01-29 | $73.61 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $78.21 | — | 2025-01-17 | $75.15 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $67.48 | $72.85 | 2025-01-09 | $68.25 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $91.25 | $79.75 | 2024-12-18 | $66.71 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $74.38 | $77.45 | 2024-12-04 | $71.31 | -4.3% | 48% | C |